Early breast cancer classified as intermediate risk by the Prosigna assay: Characteristics and treatment strategy

Authors :: Nawale Hajjaji
Delphine Bertin
Yves-Marie Robin
Jacques Bonneterre
Source :: Annals of Oncology. 29:viii68
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Medicine
Treatment strategy
Hematology
business
Intermediate risk
Early breast cancer

Full Text Access

Tools